<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01469871</url>
  </required_header>
  <id_info>
    <org_study_id>PEJ-481</org_study_id>
    <nct_id>NCT01469871</nct_id>
  </id_info>
  <brief_title>Evaluation of Three Types of Dressings After Hip Surgery</brief_title>
  <official_title>Reduction of Tape Blisters After Hip Surgery. A Prospective Evaluation of Three Types of Dressings.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital de l'Enfant-Jesus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital de l'Enfant-Jesus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if one of the new types of dressings (MEPORE PRO
      and/or MEPILEX BORDER ) will reduce the blister rate compared to the currently used HYPAFIX.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The prevalence of tape blisters after hip fracture surgery</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation between risk factors and tape blisters</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The possible link between the presence of tape blisters and hospital morbidity.</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The costs related to a tape blister.</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 8 days</time_frame>
    <description>The actual costs related to a tape blister will be calculated by adding the costs of additional dressings, the costs associated with an extended hospital stay and the additional costs associated with the use of external resources.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Tape Blisters</condition>
  <condition>Hip Surgery</condition>
  <arm_group>
    <arm_group_label>Hypafix Transparent dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Hypafix Transparent dressing, a stretchable dressing, will be used to treat the patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepore Pro dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Mepore Pro dressing, a self-adhesive perforated dressing, will be used to treat the patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mepilex Border dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Mepilex Border dressing, a self-adherent soft silicone dressing, will be used to treat the patients in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dressing of wound</intervention_name>
    <description>The wound will be dressed using the Hypafix Transparent dressing after hip surgery.</description>
    <arm_group_label>Hypafix Transparent dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dressing of wound</intervention_name>
    <description>The wound will be dressed using the Mepore Pro dressing after hip surgery.</description>
    <arm_group_label>Mepore Pro dressing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dressing of wound</intervention_name>
    <description>The wound will be dressed using the Mepilex Border dressing after hip surgery.</description>
    <arm_group_label>Mepilex Border dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female 45 years old or older

          -  Hip surgery at Hopital de l'Enfant-Jesus between 02/2009 and 01/2010 (THR,rTHR, DHS,
             screw fixation, hemiarthroplasty, resurfacing)

          -  Signed consent form

        Exclusion Criteria:

          -  Allergy to dressing

          -  Polytrauma / high energy trauma

          -  Wound at the surgical site prior to surgery

          -  Neurological deficit of operated side (hemiplegia, etc.)

          -  Bilateral fracture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephane Pelet, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital l'Enfant-Jésus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier affilié universitaire de Quebec - Hopital l'Enfant-Jesus</name>
      <address>
        <city>Quebec</city>
        <zip>G1J 1Z4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2011</study_first_submitted>
  <study_first_submitted_qc>November 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2011</study_first_posted>
  <last_update_submitted>November 9, 2011</last_update_submitted>
  <last_update_submitted_qc>November 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hopital de l'Enfant-Jesus</investigator_affiliation>
    <investigator_full_name>Pelet Stephane</investigator_full_name>
    <investigator_title>Dr Stephane Pelet MD, PhD Orthopedic surgeon</investigator_title>
  </responsible_party>
  <keyword>Dressing</keyword>
  <keyword>Blisters</keyword>
  <keyword>Silicone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blister</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

